Mercer Global Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1M | Sell |
36,255
-20,191
| -36% | -$7.85M | 0.03% | 299 |
|
|
2025
Q1 | $24.6M | Buy |
56,446
+10,246
| +22% | +$4.46M | 0.06% | 190 |
|
|
2024
Q4 | $17M | Buy |
+46,200
| New | +$17M | 0.04% | 243 |
|
|
2024
Q1 | – | Sell |
-47,038
| Closed | -$22.2M | – | 2055 |
|
|
2023
Q4 | $22.2M | Buy |
47,038
+5,255
| +13% | +$2.48M | 0.07% | 180 |
|
|
2023
Q3 | $18.2M | Buy |
41,783
+571
| +1% | +$249K | 0.07% | 175 |
|
|
2023
Q2 | $18.3M | Buy |
41,212
+172
| +0.4% | +$76.4K | 0.07% | 183 |
|
|
2023
Q1 | $18.9M | Buy |
41,040
+924
| +2% | +$425K | 0.09% | 170 |
|
|
2022
Q4 | $20.6M | Buy |
40,116
+8,656
| +28% | +$4.44M | 0.1% | 159 |
|
|
2022
Q3 | $14.3M | Buy |
31,460
+903
| +3% | +$410K | 0.08% | 180 |
|
|
2022
Q2 | $14.7M | Buy |
30,557
+227
| +0.7% | +$110K | 0.09% | 178 |
|
|
2022
Q1 | $14.9M | Buy |
30,330
+1,791
| +6% | +$880K | 0.09% | 171 |
|
|
2021
Q4 | $13.2M | Buy |
28,539
+2,096
| +8% | +$972K | 0.08% | 178 |
|
|
2021
Q3 | $9.87M | Buy |
26,443
+2,503
| +10% | +$934K | 0.07% | 228 |
|
|
2021
Q2 | $9.14M | Buy |
23,940
+2,315
| +11% | +$884K | 0.07% | 215 |
|
|
2021
Q1 | $7.76M | Buy |
21,625
+3,189
| +17% | +$1.14M | 0.07% | 221 |
|
|
2020
Q4 | $5.92M | Buy |
18,436
+9,085
| +97% | +$2.92M | 0.07% | 200 |
|
|
2020
Q3 | $2.51M | Buy |
9,351
+522
| +6% | +$140K | 0.04% | 321 |
|
|
2020
Q2 | $2.32M | Buy |
8,829
+977
| +12% | +$257K | 0.04% | 293 |
|
|
2020
Q1 | $1.78M | Buy |
7,852
+3,997
| +104% | +$908K | 0.04% | 338 |
|
|
2019
Q4 | $1.16M | Buy |
3,855
+121
| +3% | +$36.5K | 0.02% | 484 |
|
|
2019
Q3 | $896K | Buy |
3,734
+227
| +6% | +$54.5K | 0.02% | 514 |
|
|
2019
Q2 | $990K | Sell |
3,507
-267
| -7% | -$75.4K | 0.03% | 462 |
|
|
2019
Q1 | $1.08M | Buy |
+3,774
| New | +$1.08M | 0.04% | 398 |
|